Here’s a surprising twist in the world of medical science: a little chaos might actually be the key to better drug delivery. What if the secret to improving how we treat diseases like cancer and genetic disorders lies in making things a bit messier? New research from the University of Copenhagen, set to be unveiled at the Biophysical Society Annual Meeting in San Francisco this February, suggests that lipid nanoparticles (LNPs)—the unsung heroes behind mRNA vaccines—work best when their internal structure is less organized. But here’s where it gets controversial: could the precision we’ve been chasing in drug development actually be holding us back?
LNPs have been a game-changer, especially in the fight against Covid-19, but their potential extends far beyond vaccines. Scientists are now exploring their use in treating cancer, rare genetic diseases, and more. However, a major hurdle remains: only a tiny fraction of the cargo they carry—roughly one to five percent—actually gets released inside cells. This inefficiency limits their therapeutic potential. As Artu Breuer, PhD, a postdoctoral researcher in biophysics at the University of Copenhagen, puts it, ‘In cancer treatment, where cells divide rapidly, delivering too little RNA means the cells can outpace the therapy.’
To tackle this issue, Breuer and his team developed a groundbreaking high-throughput method that examines individual nanoparticles—about a million at a time—instead of just analyzing batch averages. This approach revealed something unexpected: LNPs aren’t as uniform as previously thought. In fact, they fall into two distinct categories: organized particles with neatly structured cargo, and amorphous particles with a more disorganized internal arrangement. And this is the part most people miss: the disorganized particles outperform their organized counterparts in delivering cargo inside cells.
Historically, drug developers have focused on maximizing the amount of medicine packed into each nanoparticle. But Breuer’s findings challenge this approach. Highly organized particles, it turns out, may resist releasing their cargo once they reach their target. Breuer explains, ‘In organized nanoparticles, the positively charged lipids are tightly bound to the negatively charged RNA. Even when conditions change inside the cell, these attractions keep everything locked together. But in disorganized particles, there’s some separation between the charges. When the cell’s environment shifts, the positive charges repel each other, causing the particle to break apart and release the medicine.’
This discovery suggests a paradigm shift: instead of prioritizing cargo quantity, developers might achieve better results by focusing on maintaining a disorganized internal structure that allows cargo to escape once inside cells. ‘We’re aiming in the opposite direction of what the field has been pursuing,’ Breuer notes. ‘I’m not advocating for empty nanoparticles, but we need to find a balance—enough RNA to be effective, but with a structure that’s more effective inside cells.’
Is this the future of drug delivery, or are we overlooking the benefits of precision? Could embracing a little disorder revolutionize how we treat diseases? Let us know your thoughts in the comments—this debate is just getting started.
